Pharma — India Trademark Cases
177 decisions indexed
Page 6 of 6 · 177 total
Cadila Healthcare Ltd. v.Union Of India And Ors.
Cadila Healthcare Ltd. challenged an order that rejected its petition seeking to treat a trademark opposition (filed by M/s. Wockhordt Ltd.) as abandoned. The petitioner argued that the delay in filing evidence was prejudicial. The court examined the Registrar's power to grant extensions under Section 101 of the Act and held that such an extension is permissible, thus saving the opposition proceedings.
Torrent Pharmaceuticals Ltd. v.Union Of India (Uoi) And Ors.
Torrent Pharmaceuticals Ltd. appealed against the summary dismissal of its petition challenging the Registrar's action regarding a notice of opposition filed by Welcome Foundation Ltd. The core dispute revolved around whether the statutory provisions governing the submission of evidence during trademark opposition proceedings were mandatory or directory.
Winthrop Products Inc. v.Eupharma Laboratories Ltd.
The plaintiffs sought an injunction against defendants for infringing their registered trade mark, PANADOL, and passing off. The court found that the plaintiffs were the rightful proprietors of the trade mark and that the defendants lacked any vested right to use the name. Consequently, the defendants were prevented from using or passing off the trade mark.
T.T.K. Pharma Limited v.Ag. Robapharam
The respondent claimed ownership of the registered trademark "Ossopan" and filed a suit for injunction against the appellant/defendant. During the pendency of the suit, the respondent sought to amend the plaint to correct an apparent mistake regarding the description of specified goods, which was inconsistent with the registration certificate. The High Court upheld the amendment, rejecting the appeal filed by the defendant.
Win-Medicare Limited v.Somacare Laboratories
The plaintiff, Win-Medicare Limited, filed an application for temporary injunction alleging that the defendant was manufacturing and marketing a similar pharmaceutical product under the deceptively similar trade mark DICMOL. The court examined the priority of adoption and use, finding prima facie evidence in favor of the plaintiff.
M/S. Jagsonpal Pharmaceutical Ltd. v.M/S. Senor Laboratories
The plaintiff filed a suit for injunction against the defendant on the ground of passing off, alleging that the defendant was using the identical pharmaceutical trade mark SEFLOX. The dispute centered on who had invented and used the trade mark first, with both parties presenting evidence of their respective usage dates.
Collector Of Central Excise v.Raspha Labs
The Collector of Central Excise appealed against an order stating that the words 'RL' on medicine labels did not constitute a registered trade mark, but rather served as a house mark. The Tribunal examined precedents and concluded that 'RL' was only used to project the manufacturer's image generally, thus it was merely a house mark and not proprietary in nature.
American Home Products Corporation v.Lupin Laboratories Ltd.
The plaintiff filed an infringement action alleging that the defendant was using the deceptively similar trade mark "TOROLAC" for analgesic tablets, infringing upon the plaintiff's registered trade mark "ROLAC". The court found that the marks were deceptively similar and satisfied that the plaintiffs had made out a prima facie case of infringement.
M/S. Astra Pharmaceuticals (P) Ltd. v.Collector Of Central Excise, Chandigarh
The appeal challenged the classification of pharmacopoeial Dextrose injections as patent or proprietary medicines attracting central excise duty under Tariff Item 14E. The department argued that the use of a monogram ('AP ASTRA') established a connection between the manufacturer and the medicine. The Supreme Court ruled that since the mark only identified the manufacturer, it did not establish a proprietary relationship with the specific medicine.
Astra-Idl Limited v.Ttk Pharma Limited
Astra-Idl Limited filed a suit against Ttk Pharma Limited alleging infringement and passing off of its registered trade mark 'Betaloc' (used for pharmaceutical preparations) by the defendant using the similar trade mark 'Betalong'. The court found that the plaintiff had made out a strong prima facie case for interlocutory relief, despite arguments regarding delay.
M/S. Antex India Pvt. Ltd. Bangalore v.M/S. Wander Ltd., Bombay And Etc.
The dispute arose from an agreement where Antex was authorized by Wander to manufacture and affix the trademark 'Cal-De-Ce'. When Wander arranged for a third party (Alfred Berg & Company) to produce the product, Antex sought permanent injunctions. The Madras High Court addressed writ appeals concerning the cancellation of Antex's manufacturing license.
M/S. Kamath Atul & Co. v.M/S. Cadila Laboratories (P) Ltd.
The plaintiff, M/s. Kamath Atul & Co., filed a passing off action against the defendant, M/s. Cadila Laboratories (P) Ltd., alleging that the latter was marketing an Ayurvedic herbal skin ointment under the name 'HERBINOL', which infringed upon the plaintiff's established trade mark 'HURBINOL'. The High Court dismissed the appeal but modified the temporary injunction order to restrict the defendants from marketing their product in five specific states until the suit's disposal.
Antox India (P) Ltd. v.State Drug Controller, Tamil Nadu And ...
Antox India (P) Ltd., holding a valid license for Cal-De-Ce, challenged the manufacturing license issued by the State Drug Controller, Tamil Nadu, to another party. The petitioner argued that allowing multiple manufacturers under the same trade name violates public interest and provisions of the Drugs & Cosmetics Act, 1940. The court agreed, quashing the impugned order and directing the cancellation of the second respondent's license.
Collector Of C. Ex. v.Bengal Chemicals And Pharmaceuticals
The dispute concerned whether medicines manufactured by Bengal Chemicals And Pharmaceuticals, which bore the registered trade mark 'Bengal Chemicals' on their caps, should be classified as 'Patent or Proprietary Medicines' under the Central Excises and Salt Act, 1944. The Tribunal held that merely having a registered trademark is not sufficient; the mark must indicate a proprietary interest in the medicine, especially when the medicines are already specified in pharmacopoeia.
Progro Pharmaceuticals (P) Ltd. v.Deputy Registrar Of Trade Marks, Madras
Progro Pharmaceuticals filed a writ petition challenging the rejection of its counter-statement against an opposition to the trade mark 'Helmizol'. The rejection was based on the argument that S. 21(2) is mandatory and does not allow for discretion to condone the one-month delay. The court ruled in favor of the petitioner, holding that where no outer limit is prescribed under S. 21(2), the Registrar can extend time under S. 101(l).
American Home Products Corporation v.Mac Laboratories Private Limited And Anr.
American Home Products Corporation (Appellant) sought to protect its registered trade mark 'Dristan'. Mac Laboratories Private Limited (Respondent) challenged the registration, leading to appeals regarding the validity and rectification of the trademark.
Sandoz Limited And Anr. v.Pharmaceutical And Chemical ...
The plaintiffs, holding the registered trademark 'Syntocinon', filed a suit against defendants marketing 'Synthocilin' due to alleged deceptive similarity. The trial court declined an interim injunction, leading to this appeal. The High Court considered the prior finding of deceptive similarity but opted for settlement rather than granting immediate restraint.
Union Of India v.Indo-French Pharmaceutical Company
The Union of India appealed against an order allowing Indo-French Pharmaceutical Company to clear three Indian Pharmacopoeia products without paying excise duty. The dispute centered on whether a small symbol and name used on the product label qualified as a proprietary mark under the Central Excises and Salt Act, thereby attracting excise duty.
Dolphin Laboratories Pvt. Ltd. v.Kaptab Pharmaceuticals
The plaintiff (Dolphin Laboratories) sued the defendant (Kaptab Pharmaceuticals) alleging infringement/passing off regarding the trade mark 'Amotid' for the drug Amoxycilin Tri-hydrale. The core legal controversy was whether the plaintiff, in its Section 120 suit, could restrain the defendant from filing a separate passing off suit. The court held that while the defendant must stop making unjustified threats, it retains the fundamental right to institute a passing off suit.
Amrutanjan Limited v.Amarchand Sobachand
Amrutanjan Limited sued Amarchand Sobachand for infringing its registered trade mark 'AMRUTANJAN' used on pain balm. The plaintiffs alleged that the defendant was using a deceptively similar name ('Amar's Pain Balm') and an imitation carton design, leading to consumer confusion. The court found infringement but dismissed claims for damages as passing off was not proven.
Indo-Pharma Pharmaceutical Works v.Pharmaceutical Company Of India
The plaintiff, proprietor of 'BUTACORTINDON', filed an infringement suit against the defendant, proprietor of 'BUTACORT'. The plaintiffs alleged that the defendant's use of BUTACORT constituted infringement. However, the defendants successfully argued that they were prior continuous users and thus entitled to protection under Section 33 of the Trade and Merchandise Marks Act, 1958.
Mount Mettur Pharmaceuticals Ltd. v.Ortha Pharmaceuticals Corporation
Mount Mettur Pharmaceuticals Ltd. applied for registration of its trade mark 'Utogynol', which was opposed by Ortho Pharmaceuticals Corporation due to perceived similarity with their registered trade mark 'Ortho-Gynol'. The court examined the look and sound of both names, finding that despite sharing the common element 'Gynol', the initial syllables ('Uto' vs. 'Ortho') were strikingly dissimilar.
F. Hoffmann-La Roche & Co. Ltd. v.Geoffrey Manners & Co. Pvt. Ltd.
The petitioner sought rectification of the trade mark register to remove the respondent's mark 'DROPOVIT', alleging it was deceptively similar to their registered mark 'PROTOVIT'. The case also involved determining if 'DROPOVIT' was a descriptive or invented word. The Supreme Court dismissed the appeal, finding no reasonable probability of confusion and confirming that 'DROPOVIT' was an invented word.
Mac Laboratories Private Ltd. v.American Home Products Corporation And Registrar of Trade Marks
In this 1968 Calcutta High Court appeal, Mac Laboratories Private Ltd. successfully challenged the registration of the trademark 'Dristan' belonging to American Home Products Corporation. The court ruled that the original registration was contrary to law because there was no bona fide intention by the proprietor to use the mark in India. Furthermore, the appellant argued grounds including lack of distinctiveness and deceptive similarity to other marks, ultimately leading the court to allow the appeal and rectify the register.
K.L. Chaturvedi v.State Of Madhya Pradesh And Ors.
The petitioner challenged the constitutionality of the Drugs Act, 1940, arguing that the amendment requiring mandatory disclosure of the true formula or ingredient list for his proprietary medicine 'Germs Killer' would expose his trade secret. The court upheld the amended provisions, finding them reasonable and necessary for public health and safety.
The Anglo French Drug Co., (Eastern) v.R.D. Tinaikar
This appeal challenged the decision of the Deputy Registrar of Trade Marks who held that a Registered Trade Marks Agent was entitled to be heard during opposition proceedings for trade mark registration. The petitioners argued that an agent could only 'act,' but not 'plead' before the Registrar, citing provisions of the Bombay Pleaders Act. The High Court dismissed the appeal, affirming the Deputy Registrar's finding.
A.J. Von Wulfing v.D.H. Jivandas And Co.
The plaintiffs alleged that they had established a high reputation for chemical compounds sold under the names 'Sanatogen' and 'Formamint' in India. They sued the defendants, who were importing and selling similar goods at lower rates, alleging deception through the use of the marks and resemblance in packaging. The court found that the plaintiffs were entitled to their trade mark rights and ruled that the defendants' sale constituted infringement/passing off.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.